Consolidation Therapy in Esophageal Cancer

Jeremiah T Martin

doi:10.1016/j.suc.2021.03.009

Consolidation Therapy in Esophageal Cancer

Surg Clin North Am. 2021 Jun;101(3):483-488. doi: 10.1016/j.suc.2021.03.009.

Author

Jeremiah T Martin¹

Affiliation

¹ Thoracic Surgery, Southern Ohio Medical Center, 1711 27th Street, Braunlin Building, Suite 206, Portsmouth, OH 45662, USA. Electronic address: [email protected].

PMID: 34048767
DOI: 10.1016/j.suc.2021.03.009

Abstract

Consolidation therapy describes dose intensification strategies or additional treatment performed following completion of the primary regimen. In the case of esophageal cancer, this applies to cases of potentially persistent disease after definitive multi-modality therapy, including surgery. Consolidation should also be considered for patients initially planned to undergo surgery after neoadjuvant therapy, but for any reason elected a nonoperative strategy during treatment. With the advent of targeted therapy and immunotherapy, additional options may be available for consolidation in the future.

Keywords: Adjuvant therapy; Consolidation therapy; Esophageal cancer treatment; Multimodality therapy.

Publication types

Review

MeSH terms

Chemoradiotherapy, Adjuvant*
Consolidation Chemotherapy / methods*
Esophageal Neoplasms / therapy*
Esophagectomy*
Humans
Neoadjuvant Therapy*
Treatment Outcome